Publications:

---

PAK5-stabilized Smuc confers renal cell carcinoma metastasis.

Clinical And Translational Medicine

Huo, Fu-Chun FC; Zhu, Zhi-Man ZM; Du, Qiu-Ying QY; Pei, Dong-Sheng DS

Publication Date: 2021-09

Variant appearance in text: PAK5: S573N

PubMed Link: 34586742

Variant Present in the following documents:

• Main text
• CTM2-11-e559.pdf

View BVdb publication page

---

MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway.

Journal Of Biomedical Science

Li, Tong-Tong TT; Mou, Jie J; Pan, Yao-Jie YJ; Huo, Fu-Chun FC; Du, Wen-Qi WQ; Liang, Jia J; Wang, Yang Y; Zhang, Lan-Sheng LS; Pei, Dong-Sheng DS

Publication Date: 2021-08-02

Variant appearance in text: PAK5: S573N

PubMed Link: 34340705

Variant Present in the following documents:

• Main text
• 12929_2021_Article_752.pdf

View BVdb publication page

---

P21-activated kinase 5 potentiates the chemoresistant phenotype of liver cancer.

Signal Transduction And Targeted Therapy

Zhang, Ding-Guo DG; Gong, Chan-Chan CC; Wu, Xiao-Jin XJ; Ren, Xin X; Sedaka, Randee S RS; Chen, Wei-Cong WC; Huo, Fu-Chun FC; Chen, Cheng C; Du, Wen-Qi WQ; Pei, Dong-Sheng DS

Publication Date: 2021-02-05

Variant appearance in text: PAK5: S573N

PubMed Link: 33542180

Variant Present in the following documents:

• Main text
• 41392_2020_Article_409.pdf

View BVdb publication page

---

Melanoma-associated mutants within the serine-rich domain of PAK5 direct kinase activity to mitogenic pathways.

Oncotarget

LaPak, Kyle M KM; Vroom, Dennis C DC; Garg, Ayush A AA; Guan, Xiangnan X; Hays, John L JL; Song, Jonathan W JW; Burd, Christin E CE

Publication Date: 2018-05-22

Variant appearance in text: PAK5: S573N

PubMed Link: 29875996

Variant Present in the following documents:

• Main text
• oncotarget-09-25386.pdf

View BVdb publication page

---

Targeted genetic dependency screen facilitates identification of actionable mutations in FGFR4, MAP3K9, and PAK5 in lung cancer.

Proceedings Of The National Academy Of Sciences Of The United States Of America

Fawdar, Shameem S; Trotter, Eleanor W EW; Li, Yaoyong Y; Stephenson, Natalie L NL; Hanke, Franziska F; Marusiak, Anna A AA; Edwards, Zoe C ZC; Ientile, Sara S; Waszkowycz, Bohdan B; Miller, Crispin J CJ; Brognard, John J

Publication Date: 2013-07-23

Variant appearance in text: PAK5: S573N

PubMed Link: 23836671

Variant Present in the following documents:

• Main text

View BVdb publication page

---

PAK4-6 in cancer and neuronal development.

Cellular Logistics

Minden, Audrey A

Publication Date: 2012-04-01

Variant appearance in text: PAK5: S573N

PubMed Link: 23125951

Variant Present in the following documents:

• Main text
• cl-2-95.pdf

View BVdb publication page

---

Subgroup II PAK-mediated phosphorylation regulates Ran activity during mitosis.

The Journal Of Cell Biology

Bompard, Guillaume G; Rabeharivelo, Gabriel G; Frank, Marie M; Cau, Julien J; Delsert, Claude C; Morin, Nathalie N

Publication Date: 2010-09-06

Variant appearance in text: PAK5: S573N

PubMed Link: 20805321

Variant Present in the following documents:

• Main text
• JCB_200912056.pdf

View BVdb publication page

---

PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable microtubules and dynamic actin.

Molecular Biology Of The Cell

Matenia, Dorthe D; Griesshaber, Bettina B; Li, Xiao-yu XY; Thiessen, Anja A; Johne, Cindy C; Jiao, Jian J; Mandelkow, Eckhard E; Mandelkow, Eva-Maria EM

Publication Date: 2005-09

Variant appearance in text: PAK5: S573N

PubMed Link: 16014608

Variant Present in the following documents:

• Main text

View BVdb publication page

---

PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells.

Molecular And Cellular Biology

Dan, Chuntao C; Nath, Niharika N; Liberto, Muriel M; Minden, Audrey A

Publication Date: 2002-01

Variant appearance in text: PAK5: S573N

PubMed Link: 11756552

Variant Present in the following documents:

• Main text

View BVdb publication page

---